Keno Gutierrez

Partner

Location: Amsterdam

Keno Gutierrez, PhD, MBA, is a Partner at Angelini Ventures, which he joined in 2026.

Keno brings more than 25 years of experience across biotech investing, company building, operations and advisory roles. Before joining Angelini Ventures, he was a General Partner at BGV, where he invested in and helped build therapeutics companies and served on several boards. His board experience includes Brandaris Therapeutics, which he founded, led as CEO and chaired, FundaMental Pharma, which he chaired, as well as other board roles in Brenig Therapeutics, Fibrocor Therapeutics, RougeTx and Tessellate Bio. Earlier in his career, Keno held investment roles at M Ventures and Omega Funds and worked in healthcare investment banking at Piper Sandler, management consulting at IQVIA and medical research at the UK Medical Research Council.

Keno is a Fellow of the Royal Society of Medicine. He holds a PhD in Genetics from University College London and an MBA from INSEAD. He is a named inventor on a neuroscience patent, and his research on lipid metabolism was published in Nature.